Akebia Therapeutics Inc
NASDAQ:AKBA
Wall Street
Price Targets
AKBA Price Targets Summary
Akebia Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
AKBA
is 5.1 USD
with a low forecast of 4.04 USD and a high forecast of 6.3 USD.
AKBA Last Price Targets
Akebia Therapeutics Inc
The latest public price target was made on Mar 28, 2024 by
Ed Arce
from
H.C. Wainwright
,
who expects
AKBA
stock to
rise by 303%
over the next 12 months.
You can read more about this price target by viewing
the article on TheFly.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
|
Ed Arce
H.C. Wainwright
|
6
USD
Upside 303% |
1 month ago
Mar 28, 2024
|
Akebia price target raised to $6 from $5 at H.C. Wainwright
TheFly
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is AKBA's stock price target?
Price Target
5.1
USD
According to Wall Street analysts, the average 1-year price target for
AKBA
is 5.1 USD
with a low forecast of 4.04 USD and a high forecast of 6.3 USD.
What is Akebia Therapeutics Inc's Revenue forecast?
Projected CAGR
8%
The
compound annual growth rate
of Akebia Therapeutics Inc's revenue for the next 3 years is
8%.
You don't have any saved screeners yet
